Age-related macular degeneration is one of the leading causes of sight loss globally, affecting nearly as many people as dementia; however, in the UK less than one fifth of one percent of medical research funding is spent on investigating the…
A greater understanding of the mechanics of age-related macular degeneration is our key to helping those with the disease, and even preventing its development. One area which shows promise is the effect of the Mediterranean diet. We already know this…
What does a larger and more aged population mean for our approach to eye health? This is the question posed by the Nutraceutical Business Review, who recently published our paper on MPS II and macular screening. A condensed-version of our…
New research has shown eye health nutrient lutein might be even more important for brain function. A congress recently heard that the carotenoid lutein, and others like zeaxanthin, plays a role in conjunction with omega-3 fatty acids like DHA in…
Recent studies are developing the case further that macular pigment could be a biomarker for neurodegeneration, and our latest infographic explores this topic in detail. Lutein is a key ingredient in macular pigment, and macular pigment optical density (MPOD) is…
A study of 33,068 patients has shown a link between the thinning of the retinal nerve and poor cognition – an important and clear warning of early stage Alzheimer’s disease. Researchers at Moorfields Eye Hospital and the UCL Institute of…
Exercise isn’t just for losing or maintaining a healthy weight, but to protect your vital organs and ward of illnesses, and this goes for eye health too. Several studies have been undertaken into how being active can reduce a person’s…
Sixty of the UK’s foremost eye health researchers have called for more funding into macular degeneration, describing the situation as ‘urgent’. A recently published report by the Macular Society states there is a duty on publicly funded bodies to put…
The RNIB likens sight loss to bereavement, with people experiencing long-lasting mental health ramifications as well as the physical sight loss itself. The wet form of AMD, present in about 10-15% of cases, causes permanent sight loss and very immediate…
Encouraging news from the National Eye Institute (NEI). A recent study of 647 AMD patients treated with anti-VEGF drugs for five years showed that half maintained 20/40 vision or better. The study’s authors heralded this as a huge achievement, which…